Ligand to acquire XOMA Royalty for $739 million in cash deal
Tweet Send to a Friend
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced it will acquire XOMA Royalty Corporation (NASDAQ: XOMA) for $39.00 per share in cash ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


